Fig. 2From: Triplet‐drug chemotherapy combined with anti‐EGFR antibody as an effective therapy for patients with initially unresectable metastatic colorectal cancer: a meta-analysisForest plot. The overall response rate in patients who received FOLFOXIRI + anti-EGFR antibody or FOLFOXIRIBack to article page